Micro-x Ltd. · ASX:MX1
Micro-x — Shareholder Meeting (November 2019)
14 slides from Micro-x's shareholder meeting presentation, Nov 29, 2019
Slide 1: CEO Presentation: Building sales of next generation x-ray
For personal use only Ltd ACN 153 273 735 ASX: MX1 CEO Presentation Building sales of next generation x-ray 29th November 2019 Peter Rowland Managing Director & CEO
Slide 2: Disclaimer
Disclaimer For personal use only SCOPE & LIMITATIONS This Presentation has been prepared by Micro-X Limited (Micro-X or the Company) (ASX.MX1). The Presentation is a summary only and does not contain all the information about the Company’s assets and liabilities, financial position and performance,
Slide 3: Overview
Overview For personal use only Next generation X-ray for global health and security markets • ASX listed hi-tech X-ray company based in Tonsley, Adelaide • Next generation, cold cathode, Carbon Nano Tube technology • X-ray products with significant reduction in size, weight and power • Platform tech
Slide 4: Product roadmap
Product roadmap For personal use only Planned product evolution – from current X-ray uses to solving unmet needs Mobile medical X-ray Mobile medical X-ray Counter terrorism Airport screening for Military IED Detection Nano Rover MBS MBI Launched 2019 Prototype ~ 2021 First contract Prototype end 202
Slide 5: Corporate Snapshot
Corporate Snapshot For personal use only Growth stage company with institutional and strategic investor support Share & Trading Statistics (Closing Price on 27 November 2019) Share Price $0.23 per share MX1 - Three month trading Total Shares On Issue 177.5 million to 27 Nov 2019 Options Issued 11.6
Slide 6: Business model & Strategies
Business model & Strategies For personal use only Commercialise our proprietary technology products with selected global partners • Dual Market strategy in healthcare and defence/security – based on proprietary technology • Maintain world leading in-house design and technology development capabiliti
Slide 7: New solution in mobile X-ray for healthcare
New solution in mobile X-ray for healthcare For personal use only Carestream Health is a world leader in mobile X-ray for the healthcare market • Carestream Health appointed global distributor Product Overview • FDA approved Class II Medical device • Premium positioning • True mobile X-ray device ov
Slide 8: Revised Sales & Marketing – building sales traction
Revised Sales & Marketing– building sales traction For personal use only Responding to slower than anticipated ramp up • Early quality/yield and reliability issues – resolved with insourcing • Micro-X has insourced and proven a proprietary and superior emitter • Lack of tubes from previous supplier
Slide 9: Insourcing & Manufacturing Scale up
Insourcing & Manufacturing Scale up For personal use only Next stage Expansion and vertical integration of tube supply Capacity of 85 Nano or Rover units p.m. Increases with weekend or second shift Tonsley Facility, Adelaide • > 1,000 m2 • Capacity for medium term needs • Dedicated Rover production
Slide 10: First generation Rover – on sale mid-2020
First generation Rover – on sale mid-2020 For personal use only Responding to US military interest to buy the product • U.S. Army – Medical Materiel Agency (medical procurement) • Recent demonstrations at Fort Detrick, Maryland • Interest for all three services - supporting deployments and domestic
Slide 11: MBI - Third Product in development
MBI - Third Product in development For personal use only Unmanned assessment of potential Improvised Explosive Devices • Bomb disposal technicians face life Product Characteristics threatening harm when placing • Multi-beam CNT imaging with Backscatter detector – enables one-sided X-ray image X-ray
Slide 12: Thales partnership & $10m investment
Thales partnership & $10m investment For personal use only Technology partnership with a global leader in defence and aircraft security • $10M investment via loan facility • $5m cash already received July 2019 on completion • Subject to EGM approval (to be sought by end 2019), Thales has option to c
Slide 13: Milestones - setting our new course
Milestones - setting our new course For personal use only Focused on delivering commercial outcomes for all stakeholders Early US sales of Nano Thales Partnering deal & $5m Next Stage Facility expansion CY 2019 CNT in-sourcing complete CY 2020 Beyond First Nano sales with MX1 tube Patent published -
Slide 14: Contact
For personal use only ACN 153 273 735 Peter Rowland Managing Director 1284 South Road Tonsley SA 5042 +61 8 7099 3966 admin@micro-x.com